CHLORAMPHENICOL powder United States - English - NLM (National Library of Medicine)

chloramphenicol powder

attix pharmaceuticals - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 25 kg in 25 kg

Chloramphenicol Antibiotic 0.5% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chloramphenicol antibiotic 0.5% eye drops

numark ltd - chloramphenicol - eye drops - 5mg/1ml

Chloramphenicol 1% eye ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chloramphenicol 1% eye ointment

medicom healthcare ltd - chloramphenicol - eye ointment - 10mg/1gram

CHLORAMPHENICOL SODIUM SUCCINATE INJECTION BP 1G PARENTERAL ORDINARY DRY VIALS Uganda - English - National Drug Authority

chloramphenicol sodium succinate injection bp 1g parenteral ordinary dry vials

macleods pharmaceuticals ltd - chloramphenicol sodium succinate - parenteral ordinary dry vials - 1g

CHLORAMPHENICOL FISIOPHARMA 1G Israel - English - Ministry of Health

chloramphenicol fisiopharma 1g

propharm ltd - chloramphenicol - powder for solution for injection - chloramphenicol 1 g - chloramphenicol - chloramphenicol is active against several bacteria in the following infections:- typhoid fever and salmonellosis (salmonella typhi);- bacterial meningitis (haemophilus influenzae, neisseria meningitidis);- rickettiosis (rickettsia);- brucellosis (brucella);- psittacosis (chlamydophila psittaci);- lymphogranuloma venereum (lymphogranuloma-psittacosis);- urinary infection caused by gram-negative bacteria;- infections caused by anaerobic bacteria (cocci gram-positive cocci, clostridium).and is indicated when oral administration is contraindicated or not feasible due to vomiting, diarrhea or severe sepsis .

Dobutamine-hameln 12.5 mg/ml concentrate for solution for infusion New Zealand - English - Medsafe (Medicines Safety Authority)

dobutamine-hameln 12.5 mg/ml concentrate for solution for infusion

max health limited - dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml;   - concentrate for infusion - 12.5 mg/ml - active: dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml   excipient: hydrochloric acid sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin: a. acute heart failure acute myocardial infarction, cardiogenic shock, following cardiac surgery, medicine-induced depression of cardiac contractility such as that which occurs in excessive ?-adrenergic receptor blockade. b. chronic heart failure acute decompensation of chronic congestive heart failure, temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin: acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure, low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). paediatric population: dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock. dobutamine stress echocardiography: dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. precautions apply (refer to data sheet).

Minims Chloramphenicol New Zealand - English - Medsafe (Medicines Safety Authority)

minims chloramphenicol

bausch & lomb (nz) ltd - chloramphenicol 0.5%{relative} - eye drops, solution - 0.5% w/v - active: chloramphenicol 0.5%{relative} excipient: borax boric acid purified water - chloramphenicol is indicated for the topical treatment of infections due to microorganisms sensitive to the anti-infective.

Chloramphenicol 0.5% w/v Eye Drops Ireland - English - HPRA (Health Products Regulatory Authority)

chloramphenicol 0.5% w/v eye drops

martindale pharmaceuticals ltd - chloramphenicol - eye drops, solution - 0.5 percent weight/volume - antibiotics; chloramphenicol

X - chloramphenicol palmitate powder United States - English - NLM (National Library of Medicine)

x - chloramphenicol palmitate powder

ax pharmaceutical corp - chloramphenicol palmitate (unii: 43vu4207nw) (chloramphenicol - unii:66974fr9q1) - chloramphenicol palmitate 24750 g in 25000 g

Chloramphenicol 0.5% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chloramphenicol 0.5% eye drops

actavis uk ltd - chloramphenicol - eye drops - 5mg/1ml